Equity Awards and Instruments (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

Total stock‑based compensation expense consists of the following:

	Year Ended December 31,
	2022		2021		2020
Restricted stock and RSUs expense (1)	$	40,754	$	19,917	$	4,248
Bonus Plan expense (see Note 11)	28,571		23,121		6,524
ESPP expense (see Note 13)	2,890		2,118		—
Stock option expense	2,150		3,271		6,858
Stock grants expense	450		445		319
DCP elective participant deferrals expense (2) (see Note 12)	391		173		—
IPO vested restricted stock and RSU expense	—		—		15,102
Total stock-based compensation expense (3)	$	75,206	$	49,045	$	33,051

(1)Includes acquisition‑related shares for the years ended December 31, 2022 and 2021 (see Note 4).

(2)DCP elective participant deferrals expense excludes deferred incentive bonus payable pursuant to the Bonus Plan.

(3)As of December 31, 2022 and 2021, $7,300 and $6,749 remained in Accruals and other current liabilities in the consolidated balance sheets, respectively.

Total stock‑based compensation expense is included in the consolidated statements of operations as follows:

	Year Ended December 31,
	2022		2021		2020
Cost of subscriptions and licenses	$	2,781	$	1,442	$	960
Cost of services	2,055		1,257		2,939
Research and development	27,209		19,740		12,105
Selling and marketing	8,898		5,980		6,692
General and administrative	34,263		20,626		10,355
Total stock-based compensation expense	$	75,206	$	49,045	$	33,051

Schedule of Options

The following is a summary of stock option activity and related information under the Company’s applicable equity incentive plans:

				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
	Stock	Exercise Price		Contractual	Intrinsic
	Options	Per Share		Life (in years)	Value
Outstanding, December 31, 2021	6,917,925	$	5.26
Exercised	(3,011,160)	4.86
Forfeited and expired	(112,250)	5.65
Outstanding, December 31, 2022	3,794,515	$	5.57	0.9	$	119,096
Exercisable, December 31, 2022	2,849,765	$	5.52	0.8	$	89,600

Schedule of Restricted Stock and Restricted Stock Unit Activity

The following is a summary of unvested restricted stock and RSU activity and related information under the Company’s applicable equity incentive plans:

							Time-		Performance-
							Based		Based
			Time-		Performance-		Weighted		Weighted
	Total		Based		Based		Average		Average
	Restricted		Restricted		Restricted		Grant Date		Grant Date
	Stock		Stock		Stock		Fair Value		Fair Value
	and RSUs		and RSUs		and RSUs		Per Share		Per Share
Unvested, December 31, 2021	1,708,545		1,611,862		96,683	(4)	$	32.81	$	49.93
Granted	2,140,710	(1)	1,777,937	(3)	362,773	(5)	38.18		38.21
Vested	(600,382)		(509,212)		(91,170)	(4)	30.48		49.93
Forfeited and canceled	(180,022)		(174,509)		(5,513)		34.29		49.93
Unvested, December 31, 2022	3,068,851	(2)	2,706,078		362,773		$	36.67	$	38.21

(1)For the year ended December 31, 2022, the Company only granted RSUs.

(2)Includes 61,644 RSUs which are expected to be settled in cash.

(3)Includes 199,076 time‑based RSUs granted during the three months ended March 31, 2022 to certain officers and key employees, which cliff vest on January 31, 2025.

(4)Relates to the 2021 annual performance period. Total stock‑based compensation expense associated with these awards was fully recognized as of December 31, 2021.

(5)Primarily relates to the 2022 annual performance period, except for 185,186 performance‑based RSUs granted during the year ended December 31, 2022 with extraordinary terms, which are described below.